Is the Barclays share price a brilliant FTSE 100 bargain or a value trap?

Is Barclays plc (LON: BARC) a hot contrarian buy or a FTSE 100 (INDEXFTSE: UKX) share that should be avoided at all costs?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I have spent no little time warning of the difficulties facing banks with significant UK exposure such as Barclays (LSE: BARC).

The FTSE 100 business may have significant operations in the US, however it remains dependent upon strong economic conditions in Britain to keep growing earnings.

Latest GDP figures may have shown quarter-on-quarter growth in its home country rising from 0.2% in Q1 to 0.4% in Q2, but this is not exactly suggestive of a robust economic climate. Indeed, the Office for National Statistics numbers showed economic expansion cooingl from 0.3% in May to 0.1% in June, giving broker predictions of further slippage in the remainder of the year plenty of credibility.

PPI pains

As if a rough trading environment was not enough to contend with, the age-old problem of PPI-related misconduct is still to relinquish its grip on Britain’s banks.

Sure, next August’s deadline for new claims means that there is at last some light at the end of the tunnel for the likes of Barclays. But don’t be fooled: there is still plenty of time for the business to endure more earnings-crushing costs.

The newsflow surrounding this issue certainly hasn’t been favourable for the Footsie firm. It stashed away an extra £400m in the first half of 2018, taking total provisions to £9.6bn as of June. Barclays said that it “views its current PPI provision as appropriate, but will continue to closely monitor complaint trends and the associated provision adequacy.”

I’m not sure that this optimistic assessment is all that reassuring, though. Barclays had previously advised of the impact that the Financial Conduct Authority’s ubiquitous PPI advertising campaigns have had in pushing claims numbers higher again, and this was illustrated when the bank advised that it had received and processed another 2.3m claims between January and June.

It’s not a stretch to imagine the number of claimants surging in the final year of the redress period amid an inevitable media frenzy. But this is, of course, not the only misconduct headache Barclays is still having to deal with.

The £1.4bn settlement Barclays brokered with the US Justice Department in March over the sale of mortgage-backed securities prior to the financial crisis a decade ago played a large part in the bank’s first-half profits sinking 29% year-on-year to £1.7bn. And further hefty charges could be coming down the line after the Serious Fraud Office last month applied to the high Court to reinstate charges related to fundraising involving Qatar during the crisis.

Cheap but chilling

But aren’t these problems factored into the Barclays share price? Well no, in my opinion.

Sure, the business may carry a conventionally cheap forward P/E ratio of 9.4 times. However, Barclays has long traded below the benchmark of 10 times or below that commonly reflects high-risk stocks, but this hasn’t stopped its market value from steadily eroding (down by 8% since the start of 2018 alone).

City analysts have been busy downgrading their earnings estimates for the bank in recent months. And the chances of more painful reductions being as high as they are makes Barclays an unappealing stock pick right now.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »